cartilage-derived inhibitor
cartilage-derived inhibitor
Fringe oncologyAn angiogenic macroprotein abundant in shark cartilage, which allegedly decreased tumour formation in sharks.
Molecular medicine
A natural anti-angiogenesis factor for treating solid tumours, which was being developed in the mid-1990s by Boston Life Sciences. The data on the efficacy of cartilage proved compellingly underwhelming enough that all work on developing such products for treating cancer was abandoned.